Production Officer at Acadia Pharmaceuticals

Mumbai, Maharashtra, India

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

M. Sc. (Organic Chemistry)
At least 3 - 5 years’ experience in API preferably cGMP
Knowledge of Process, Equipment & Quality System
Basic knowledge of Computer System Operation
Required Competencies: Production Management, Execution as per plan, Handling & Troubleshooting of Equipment & process
Hands on experience of ERP & DCS System

Responsibilities

Execution of production plan using pre-approved procedures, protocols & manufacturing records to comply cGMP & EHS norms
Ensuring cleaning of area & equipment
Escalation of issues / failures to Superior
Handling DCS Operation & issues escalation in timely manner
Actively participate & support in the investigation of deviations/OOS/OOT & provide support to production for defining Corrective & Preventive Actions
Actively participate in Audits: Regulatory Inspections/ Internal Audits etc
Responsible to train new joiners for on-job trainings
Looking after Tank Farm Area: Unloading & Loading of Tanker along with Planning by involving Supply Chain Team
Reconciliation of Liquid RM. Creation of Purchase Orders. Batch preparations & closer with required documentations
RM Requisitions, Raw Material Dispensing
Knowledge of Quality Related Documentation like SOP, BMR, BPR, Validation & Qualification

Skills

cGMP

DCS Operation

ERP

Organic Chemistry

Production Management

Equipment Troubleshooting

Quality Systems

SOP

BMR

BPR

API Production

Regulatory Audits

Batch Manufacturing

Validation

Qualification

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free